Furthermore, the impact of cathepsin B on tumour formation and progression has been confirmed in multiple models, including the pancreatic cancer RIP1-Tag2 model [259] and the renal cell carcinoma xenograft model [267]. Here, CTSB is linked to familial pancreatic carcinoma.